Lung Cancer Updates
Lung Cancer Updates
Adjuvant vs. neoadjuvant? What has ASCO 2022 taught us regarding resectable NSCLC?
Phase 3 trials are needed to determine whether neoadjuvant chemo/immunotherapy outperforms adjuvant chemo/immunotherapy.
Commentary
Climate change and air pollution seen through the cancer lens
The increase in the Earth’s temperature causes extreme weather events which will inevitably impact our patients.